Q10813 (Q10813): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item) |
||||||||||||||
| Property / EU contribution | |||||||||||||||
225,000.0 Czech koruna
| |||||||||||||||
| Property / EU contribution: 225,000.0 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
9,000.0 Euro
| |||||||||||||||
| Property / EU contribution: 9,000.0 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / EU contribution: 9,000.0 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / EU contribution: 9,000.0 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
| Property / budget | |||||||||||||||
300,000.0 Czech koruna
| |||||||||||||||
| Property / budget: 300,000.0 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / budget | |||||||||||||||
12,000.0 Euro
| |||||||||||||||
| Property / budget: 12,000.0 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / budget: 12,000.0 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / budget: 12,000.0 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
Revision as of 23:11, 11 February 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project in Czech Republic financed by DG Regio |
Statements
225,000.0 Czech koruna
0 references
300,000.0 Czech koruna
0 references
75 percent
0 references
11 August 2017
0 references
3 January 2018
0 references
19 February 2018
0 references
mcePharma s. r. o.
0 references
49°46'2.53"N, 18°0'27.29"E
0 references
74301
0 references
Projekt vývoj technologie a produktu - doplňku stravy pozitivně ovlivňujícího usínání a spánek, bude založen na bázi účinných bylinných extraktů v inovativní uživatelské podobě ve formě sticků, tablet nebo kapslí dle výsledků výzkumu zprostředkovaného výzkumnou organizací. Uvedením na trh opravdu účinného doplňku stravy získá společnost ojedinělé postavení na trhu a bude moci dále rozvíjet spolupráci i s ostatními výzkumnými organizacemi. a. (Czech)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/16_045/0010686
0 references